Data Science

The data analytics expert answers questions about Frances Haugen’s testimony and tech regulation, and why apps are so addictive.

Kristina García ・October 27, 2021

Amy Gutmann Hall, slated for completion in 2024, will centralize resources and support cross-disciplinary collaborations that harness expertise, research, and data across campus.

Erica K. Brockmeier ・October 1, 2021

The School of Engineering and Applied Science’s new data science building unveiled its new name, Amy Gutmann Hall, honoring Penn’s eight and longest-serving president.

Ron Ozio, Evan Lerner ・October 1, 2021

Wharton’s Kartik Hosanagar launched Jumpcut, a startup to help Hollywood create more inclusive content by relying on data to show industry leaders that audiences are hungry for a wider range of representation.

From Knowledge at Wharton ・July 13, 2021

A new analysis found that overall mobility in large U.S. cities has yet to return to pre-pandemic levels, and some are also experiencing changing segregation patterns, with potential implications that could last well beyond the pandemic.

Erica K. Brockmeier ・May 10, 2021

Ken Steif’s new book, “Public Policy Analytics: Code & Context for Data Science in Government,” available online and in print, provides guidance for how governments and policymakers can use data and algorithms to solve complex service-delivery problems.

Erica K. Brockmeier ・March 11, 2021

Wharton’s Dean Knox discusses his research on racial bias in policing, and how retrospective data analysis can help inform future practices.

From Knowledge at Wharton ・October 30, 2020

Regina Smalls Baker of the School of Arts & Sciences and Amy Castro Baker of the School of Social Policy & Practice explore how data can be better used to analyze and address poverty.

Brandon Baker ・October 28, 2020

Experts across Penn share their insights on how data and data science affect their fields in the context of an ongoing pandemic.

Katherine Unger Baillie, Michele W. Berger, Erica K. Brockmeier ・October 28, 2020

The specialized field of neuroscience, optogenetics, shows clinical promise for conditions like epilepsy and Parkinson’s. But before human trials can get fully underway, the field must better understand a crucial intermediate step, aided by 45 labs in nine countries sharing information.

Michele W. Berger ・October 19, 2020